Skip to content
‹ Back to IndustriesHealthcare

The Instrument Tracking Data Goldmine

Hank Balch, founder and President of Beyond Clean, joined host Hilary Kennedy on ConCensis to discuss how instrument tracking data can be a resume goldmine in today’s sterile processing landscape. Balch has a long and extensive resume filled with of industry awards, blogs, social media prowess and conference speeches. Balch started as a frontline technician…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Censis on MarketScale.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Hank Balch, founder and President of Beyond Clean, joined host Hilary Kennedy on ConCensis to discuss how instrument tracking data can be a resume goldmine in today’s sterile processing landscape. Balch has a long and extensive resume filled with of industry awards, blogs, social media prowess and conference speeches.

Balch started as a frontline technician in instrument reprocessing. He spoke about how his work in sterile processing changed after becoming a father, when he realized that when it comes to little ones going into surgery, “there is no margin for error.”

“The fatherhood piece is baked into everything I do,” said Balch. He described the industry as being very personal. When it comes to sterile processing, there has been a debate for many years about whether there should be greater background requirements since a higher education degree is not currently an entry-level requirement. Balch weighed both the advantages and disadvantages to this and the potential career opportunities it provides.

For Balch, he doesn’t think career experience is the only indicator of a good job candidate. “We want data that can say ‘I contributed this to the productivity and to the efficiency and to the safety of my department,’” said Balch. He cited total instruments processed and total trays assembled as indicators to look for to defray challenges in the recruiting process.

Balch also discussed how this data could positively impact issues with pay rate in the industry. Recent data has highlighted the significant impact of sterile processors, which is also helping to beef up resumes. “It’s the first step to begin this data-driven conversation at the HR level… that your resume can get to the top of the pile.”

Balch encourages employees to advocate for their departments to track instrument data if they are not already tracking it. “Now everyone in the department will be better positioned to be more competitive in the workplace or the industry as a whole because they can get access to their instrument data.”

Interested in learning more about Censis Technologies’ surgical asset management platform? Visit Censis.com.

Censis

Part of this channel

Censis

Surgical instrument management software for over 1,300 U.S. hospitals.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Caris launches blood-based treatment response monitoring as Q3 revenue rises 27%

Caris launches blood-based treatment response monitoring as Q3 revenue rises 27%

Caris Life Sciences completed approximately 61,500 clinical cases in Q3 2026 and raised 2026 revenue guidance to $1.04-$1.05 billion. Caris Assure is now available for therapeutic response monitoring, and Caris Confirm, a minimal residual disease assay, is targeted to launch before year-end.

  • 01Caris said higher operating expenses were driven primarily by headcount-related costs, research and development investment and marketing.
  • 02Caris Assure is now available for therapeutic response monitoring, and Caris Confirm, a whole genome, tumor-informed assay for minimal residual disease, is targeted to launch before year-end.
  • 03Caris reaffirms its guidance for clinical therapy selection volume growth of approximately 20%.

Nov 8, 2026

Denials get a queue, underpayments just look like paid claims

Denials get a queue, underpayments just look like paid claims

Underpayments in healthcare revenue cycle operations lack the visibility of denied claims because they don't trigger alerts or queue workflows. Without dedicated ownership and line-level verification against contract terms, paid claims that fall short of their contractual amount pass through undetected.

  • 01Denial workflows activate on rejection events, but underpayments produce no event, leaving paid claims unverified by default.
  • 02The speaker says many provider groups lack line-level contract intelligence to check each paid line against the applicable terms.
  • 03Payment received and payment checked are separate tasks: one verifies acceptance, the other verifies correctness—and the second often has no assigned owner.

Nov 6, 2026

A zero-paid claim line is not automatically an underpayment

A zero-paid claim line is not automatically an underpayment

A zero payment on a claim line isn't automatically an underpayment; contract terms, particularly packaging rules, determine whether zero is correct. Chasing unsupported findings damages credibility with payers and weakens the position of legitimate disputes, so revenue cycle teams must verify the full contract terms and effective dates before treating any payment difference as a finding.

  • 01When a contract packages add-ons into the primary procedure, the add-on line may legitimately show zero payment because it is folded into the primary procedure reimbursement.
  • 02Pursuing payment differences that lack contract support burns credibility with payers and can weaken the team’s position on later disputes, including valid ones.
  • 03Always verify the complete contract terms, fee schedules, carve-outs, amendments, and the specific version in effect on the date of service before treating a payment variance as a recoverable underpayment.

Nov 6, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512